Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ACC, CXP, MAT

KALY Confirms Consolidation Plans to Focus on $50 Billion Cannabis Biopharmaceutical Market Opportunity


DALLAS, Jan. 15, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today confirmed plans announced for the first time yesterday to consolidate its business structure and focus on its Cannabis Biopharmaceutical Technology. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions.  The technology has been valued at $50 million in conjunction with a recent acquisition offer that ALYI management passed on. In reaction to the offer, management has refined its ongoing business plans with the intent of consolidating and concentrating focus on its Cannabis Biopharmaceutical Technology. The cannabis biopharmaceutical market is anticipated to reach $50 billion by 2029. In conjunction with the consolidation, management plans to spin-off its other lines of business. Specifically, ALYI plans to spin-off its general agricultural CBD extraction business and CBD confections business. While ALYI will continue to generate licensing revenue from the extraction and confection businesses, the day to day management and operations will be spun-off. A specific spin-off structure has not yet been defined. Spin-off details are anticipated to be released next month.

To stay abreast of the latest developments and learn more about the company visit  https://www.kali-extracts.com/.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Frederick Ferri
ir@kali-extracts.com
+1(214) 210-0459

SOURCE Kali-Extracts, Inc.


These press releases may also interest you

at 04:00
With learning on mobile devices becoming the new norm, learners want information on-demand, in the form of bite-sized modules. To help training and L&D professionals meet this demand, CommLab India, the global leader in rapid eLearning solutions,...

at 03:23
Tuniu Corporation ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019, before the...

3 avr 2020
One-day mobile collections for COVID-19 testing specimens are continuing this weekend and into early next week, with the University of Mississippi Medical Center, Mississippi State Department of Health, Mississippi Emergency Management Agency and...

3 avr 2020
CureApp, Inc. (Head Office, Chuo-ku, Tokyo; President and CEO, Kohta Satake, M.D.), developer of software as a medical device "Digital Therapeutics" mobile applications, has launched a Phase 3 multicenter, randomized comparative study (clinical...

3 avr 2020
LiveShop Inc., an e-commerce platform to enable local shops to sell easily to their local buyers, has decided to offer their platform to all sellers in the U.S. and U.K. Company announcement: With social distancing and stay-at-home directives in...

3 avr 2020
Technavio has been monitoring the artificial intelligence (AI) in construction market and it is poised to grow by USD 1.13 billion during 2019-2023. The report offers an up-to-date analysis regarding the current market scenario, latest trends and...



News published on 15 january 2020 at 08:00 and distributed by: